Added Clinical Value of 18F-FDG-PET/CT to Stage Patients With High-Risk Non-Muscle Invasive Bladder Cancer Before Radical Cystectomy-Reference-Cited by-同舟云学术

Added Clinical Value of 18F-FDG-PET/CT to Stage Patients With High-Risk Non-Muscle Invasive Bladder Cancer Before Radical Cystectomy

Published:2023-06 Issue:3 Volume:21 Page:342-348
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

van Ginkel Noor^ORCID,van Gennep Erik J.,Oosterbaan Liselot,Greidanus Joyce,Boellaard Thierry N.,Wondergem Maurits,Vis André N.,de Reijke Theo M.,van Rhijn Bas W.G.,Mertens Laura S.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference28 articles.

1. Bladder Cancer: a review;Lenis;JAMA,2020

2. European association of urology guidelines on non–muscle-invasive bladder Cancer (Ta, T1, and Carcinoma in Situ);Babjuk;Eur Urol,2022

3. European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC guidelines panel;Sylvester;Eur Urol,2021

4. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials;Sylvester;Eur Urol,2006

5. Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder Cancer;Witjes;Eur Urol,2017

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of response to gemcitabine plus cisplatin-based chemotherapy using positron emission computed tomography for metastatic bladder cancer;World Journal of Clinical Cases;2023-12-26